News & HighlightsNews
Jeffrey V. Ravetch receives 2017 Ross Prize in Molecular Medicine
Jeffrey V. Ravetch, Theresa and Eugene M. Lang Professor and head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology, has won the 2017 Ross Prize in Molecular Medicine. The award, given by The Feinstein Institute for Medical Research and its journal Molecular Medicine, honors s...
Carolyn Walch Slayman, Rockefeller alumna and pioneer woman in science, dies at 79
Carolyn Walch Slayman, who was one of the first women to graduate from Rockefeller’s Ph.D. program, died last December at the age of 79. Dr. Slayman spent nearly 50 years at the Yale School of Medicine, where she was Sterling Professor of Genetics and deputy dean for academic and scientific affai...
Mouse studies offer new insights about cocaine’s effect on the brain
 Cocaine is one of the most addictive substances known to man, and for good reason: By acting on levels of the “feel-good” chemical dopamine, it produces a tremendous sensation of euphoria. Now the laboratory of Rockefeller University Professor and Nobel Laureate Paul Greengard has shown...
Encouraging clinical results for an antibody drug to prevent or treat HIV
A new biologic agent—the most potent of its kind so far—is showing early promise as part of a potential new strategy for treating HIV. The drug, known as 10-1074, may also offer a new way to prevent viral infection in people who are at high risk to acquire HIV, the virus that causes AIDS. ...
Discovery helps explain why only some people develop life-threatening dengue infections
For most people who contract it, dengue fever is a relatively mild-mannered disease—at least the first time around. For some, however, a subsequent infection by the virus unleashes a vicious and potentially deadly illness. New research from a team based at The Rockefeller University has begun t...
Rockefeller president Richard P. Lifton releases statement on U.S. immigration policy
In response to an executive order on immigration issued by President Donald J. Trump Friday, Rockefeller University President Richard P. Lifton today released the following statement: We at Rockefeller University, a world-renowned center for research in the biomedical sciences, oppose both the sp...
Antibody combination puts HIV on the ropes
Without antiretroviral drug treatment, the majority of people infected with HIV ultimately develop AIDS, as the virus changes and evolves beyond the body’s ability to control it. But a small group of infected individuals—called elite controllers—possess immune systems capable of defeating the ...
Elaine Fuchs wins 2017 McEwen Award for Innovation
Elaine Fuchs, Rebecca C. Lancefield Professor and head of the Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, has been honored with the 2017 McEwen Award for Innovation. The prize, given by the International Society for Stem Cell Research, recognizes groundbreaking wo...
MacKinnon lab charts the anatomy of three molecular channels
Using a state-of-the-art imaging technology in which molecules are deep frozen, scientists in Roderick MacKinnon’s lab at Rockefeller University have reconstructed in unprecedented detail the three-dimensional architecture of three channels that provide a path for specific types of ions to travel...
Biophysicist Gregory M. Alushin receives White House honor for early career scientists
Gregory M. Alushin, assistant professor and head of the Laboratory of Structural Biophysics and Mechanobiology, has been chosen by President Obama as one of 102 researchers to receive the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the U.S. government ...
View
View